![Robert Whalen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Whalen
Nessuna posizione attualmente
Storia della carriera di Robert Whalen
Precedenti posizioni note di Robert Whalen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - | - |
Altravax, Inc.
![]() Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Direttore/Membro del Consiglio | 01/01/2009 | - |
Direttore Tecnico/Scientifico/R&S | 19/05/2011 | - | |
Fondatore | 19/05/2011 | - |
Formazione di Robert Whalen
Harvard University | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Altravax, Inc.
![]() Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Health Technology |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
- Borsa valori
- Insiders
- Robert Whalen
- Esperienza